There is growing interest in research transparency and reproducibility in economics and other scientific fields. We survey existing work on these topics within economics and discuss the evidence suggesting that publication bias, inability to replicate, and specification searching remain widespread problems in the discipline. We next discuss recent progress in this area, including improved research design, study registration and pre-analysis plans, disclosure standards, and open sharing of data and materials, and draw on experiences in both economics and other social sciences. We discuss areas where consensus is emerging on new practices as well as approaches that remain controversial and speculate about the most effective ways to make economics research more accurate, credible, and reproducible in the future.
A ReproZip demo has been accepted at SIGMOD 2016: "ReproZip: Computational Reproducibility With Ease." F. Chirigati, R. Rampin, D. Shasha, and J. Freire.
The 2016 GBSI Summit—"Research Reproducibility: Innovative Solutions to Drive Quality" welcomed premiere life science thought leaders, including Arizona State University biomarker researcher Joshua LaBaer, MD, PhD, and science correspondent and moderator Richard Harris (currently on leave from National Public Radio as a visiting scholar this spring at Arizona State University), to explore the driving forces and profound impacts behind the issues.
A presentation by Philip B. Stark of University of California at Berkeley that gives a great 101-style look into what the everyday researcher can do to make their science more reproducible.
Adam Marcus, cofounder of Retraction Watch and the Center for Scientific Integrity, will give a free lecture about issues in scholarly science publishing at 4 p.m. Friday, Feb. 19, in 103 Reid Hall at Montana State University.
The Summit will also introduce GBSI’s Reproducibility2020, an action plan for the biomedical research community to significantly improve the quality of research by 2020 targeting: 1) improved validation and standardization of biological reagents; 2) better tools and technologies to expand open access for reporting and sharing protocols and data; and 3) increased training that emphasizes rigorous study design and practice.